In Vivo Mapping of Catecholaminergic Loss and Iron Deposition in Huntington's Disease
Authors:
- Edoardo R. de NataleENEdoardo R. de Natale
- Heather WilsonHWHeather Wilson
- Efstratios KaravasilisEKEfstratios Karavasilis
- Athanasia LiozidouALAthanasia Liozidou
- Chrisoula KartanouCKChrisoula Kartanou
- Georgios VelonakisGVGeorgios Velonakis
- Jens KuhleJKJens Kuhle
- Ioannis ZalonisIZIoannis Zalonis
- Georgia KaradimaGKGeorgia Karadima
- Leonidas StefanisLSLeonidas Stefanis
- Georgios KoutsisGKGeorgios Koutsis
- Marios PolitisMPMarios Politis
Open Access
- 12 February 2026
- journal article
- Published by Wiley in Movement Disorders
- Vol. 41 (5) , 1257-1267
Abstract
Background: The pathophysiology of Huntington's disease (HD) remains obscure. Magnetic resonance imaging (MRI) can reveal in vivo molecular changes related to disease pathology. Objectives: To investigate catecholaminergic neuronal integrity and subcortical brain iron accumulation in HD employing neuromelanin‐sensitive MRI, and quantitative susceptibility mapping (QSM‐MRI). Methods: Twenty‐five HD gene expansion carriers (HDGECs; 11 premanifest, mean predicted phenoconversion time 21.25 ± 8.28 years) and 25 healthy controls (HC) underwent clinical investigation, measurement of plasma neurofilament light chain (NfL) levels, neuromelanin‐sensitive, and QSM‐MRI on a 3 T scanner. For neuromelanin analysis, the substantia nigra (SN) and locus coeruleus (LC) areas and contrast‐to‐noise ratio (CNR) were computed. Regions of interest from the MuSus100 atlas were segmented for QSM‐MRI analysis, and susceptibility values extracted using the whole brain mask as reference. Results: Manifest HDGECs showed, on neuromelanin‐sensitive MRI analysis, reduced LC and SN areas, and LC CNR compared with HC ( P < 0.001). QSM analysis demonstrated increased susceptibility values in caudate, putamen, external and internal pallidum, and the subthalamic nucleus of manifest HGDECs ( P < 0.001). Higher susceptibility values in these regions correlated with clinical markers of disease burden, higher plasma NfL, and poorer neuropsychological outcomes in multiple domains ( P < 0.05). Smaller LC area correlated with higher plasma NfL ( P = 0.029). Higher susceptibility values in the caudate and putamen correlated with lower SN CNR ( P < 0.05). Conclusions: Our findings confirm widespread iron subcortical accumulation in HD, reveal significant noradrenergic neuronal loss, and describe dopaminergic alteration which may reflect ongoing pathology along the nigrostriatal pathway. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.Keywords
This publication has 46 references indexed in Scilit:
- Nuclear translocation of STAT5 initiates iron overload in huntington’s disease by up-regulating IRP1 expressionMetabolic Brain Disease, 2024
- Regional age-related changes of neuromelanin and iron in the substantia nigra based on neuromelanin accumulation and iron depositionEuropean Radiology, 2023
- Altered brain iron content and deposition rate in Huntington’s disease as indicated by quantitative susceptibility MRIJournal of Neuroscience Research, 2018
- The role of iron in gray matter degeneration in Huntington's disease: A magnetic resonance imaging studyHuman Brain Mapping, 2014
- Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodiesNeuroradiology, 2013
- Cerebral glucose metabolism and striatal 18F-Dopa uptake by PET in cases of chorea with or without dementiaJournal of the Neurological Sciences, 1993
- Locus Coeruleus Involvement in Huntington's DiseaseArchives of Neurology, 1992
- A quantitative investigation of the substantia nigra in Huntington's diseaseAnnals of Neurology, 1989
- Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatumAnnals of Neurology, 1987
- A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural markerJournal of Comparative Neurology, 1981